CASP1 and prostate carcinoma: Another study used non-cancerous prostate cell line PNT2 treated with extracellular vesicles (EVs) isolated from advanced prostate cancer PC3 cells (PC3-EVs) as a model to assess caspase-1–mediated IL-1β maturation after 24 hours of EV treatment.